Электронный архив

Просмотр Публикации сотрудников КФУ Scopus по автору "Kitaeva K.V."

Просмотр Публикации сотрудников КФУ Scopus по автору "Kitaeva K.V."

Отсортировать по:Сортировать:Результаты поиска на странице:

  • Cell Culture Based in vitro Test Systems for Anticancer Drug Screening 
    Kitaeva K.V.; Rutland C.S.; Rizvanov A.A.; Solovyeva V.V. (2020)
    © Copyright © 2020 Kitaeva, Rutland, Rizvanov and Solovyeva. The development of new high-tech systems for screening anticancer drugs is one of the main problems of preclinical screening. Poor correlation between preclinical ...
  • Contribution of multipotent mesenchymal stromal cells in the tumor microenvironment and carcinogenesis 
    Tazetdinova L.G.; Mullagulova A.I.; Solovyeva V.V.; Chulpanova D.S.; Kitaeva K.V.; Rizvanov A.A. (2021)
    Carcinogenesis is a complex and dynamic process, an important part of which is the formation of the tumor microenvironment, which is an integral part of malignant tumors and plays an important role in their progression. ...
  • Current trends in cancer immunotherapy 
    Filin I.Y.; Solovyeva V.V.; Kitaeva K.V.; Rutland C.S.; Rizvanov A.A. (2020)
    © 2020 by the authors. Licensee MDPI, Basel, Switzerland. The search for an effective drug to treat oncological diseases, which have become the main scourge of mankind, has generated a lot of methods for studying this ...
  • Inflammatory Bowel Disease-Associated Changes in the Gut: Focus on Kazan Patients 
    Lo Sasso G.; Khachatryan L.; Kondylis A.; Battey J.N.D.; Sierro N.; Danilova N.A.; Grigoryeva T.V.; Markelova M.I.; Khusnutdinova D.R.; Laikov A.V.; Salafutdinov I.I.; Romanova Y.D.; Siniagina M.N.; Vasiliev I.Y.; Boulygina E.A.; Solovyeva V.V.; Garanina E.E.; Kitaeva K.V.; Ivanov K.Y.; Chulpanova D.S.; Kletenkov K.S.; Valeeva A.R.; Odintsova A.K.; Ardatskaya M.D.; Abdulkhakov R.A.; Ivanov N.V.; Peitsch M.C.; Hoeng J.; Abdulkhakov S.R. (2021)
    Background: Several studies have highlighted the role of host-microbiome interactions in the pathogenesis of inflammatory bowel disease (IBD), resulting in an increasing amount of data mainly focusing on Western patients. ...
  • Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches 
    Shaimardanova A.A.; Chulpanova D.S.; Solovyeva V.V.; Mullagulova A.I.; Kitaeva K.V.; Allegrucci C.; Rizvanov A.A. (2020)
    © Copyright © 2020 Shaimardanova, Chulpanova, Solovyeva, Mullagulova, Kitaeva, Allegrucci and Rizvanov. Metachromatic leukodystrophy is a lysosomal storage disease, which is characterized by damage of the myelin sheath ...
  • Modern methods of preclinical anticancer drug screening using test systems based on cell cultures 
    Kitaeva K.V.; Rizvanov A.A.; Solovyeva V.V. (2021)
    Preclinical screening of medicinal drugs for novel anti-cancer treatments faces a problem of a rational approach to primary screening of substances with antitumor activity. Low correlation between in vitro and in vivo ...
  • Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy 
    Chulpanova D.S.; Kitaeva K.V.; Green A.R.; Rizvanov A.A.; Solovyeva V.V. (2020)
    © Copyright © 2020 Chulpanova, Kitaeva, Green, Rizvanov and Solovyeva. Cytokine-based immunotherapy is a promising field in the cancer treatment, since cytokines, as proteins of the immune system, are able to modulate the ...
  • Mouse tumor models for advanced cancer immunotherapy 
    Chulpanova D.S.; Kitaeva K.V.; Rutland C.S.; Rizvanov A.A.; Solovyeva V.V. (2020)
    © 2020 by the authors. Licensee MDPI, Basel, Switzerland. Recent advances in the development of new methods of cancer immunotherapy require the production of complex cancer animal models that reliably reflect the complexity ...
  • Recent Advances in Experimental Dendritic Cell Vaccines for Cancer 
    Filin I.Y.; Kitaeva K.V.; Rutland C.S.; Rizvanov A.A.; Solovyeva V.V. (2021)
    The development of immunotherapeutic methods for the treatment of oncological diseases have made it possible to improve the effectiveness of standard therapies. There was no breakthrough after first using of personalized ...
  • Tay-Sachs disease: Diagnostic, modeling and treatment approaches 
    Solovyeva V.V.; Shaimardanova A.A.; Chulpanova D.S.; Kitaeva K.V.; Rizvanov A.A. (2020)
    © 2020, Human Stem Cell Institute. All rights reserved. Tay-Sachs disease (OMIM 272800) belongs to the group of autosomal-recessive disorders, caused by β-hexosaminidase A (HexA) enzyme deficiency, resulting in GM2-ganglioside ...

Поиск в электронном архиве


Расширенный поиск

Просмотр

Моя учетная запись